The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Med.
Sec. Rheumatology
Volume 12 - 2025 |
doi: 10.3389/fmed.2025.1526218
Burden of Rheumatoid Arthritis in India from 1990 to 2021: Insights from the Global Burden of Disease Database
Provisionally accepted- Tianjin Medical University General Hospital, Tianjin, China
Objective: Rheumatoid arthritis (RA) significantly impacts individual health and society. This study aims to analyze the burden of RA in India from 1990 to 2021 and provide predictions to inform national prevention and control strategies.Methods: Utilizing data from the 2021 Global Burden of Disease (GBD) database, this study describes changes in incidence, prevalence, and Disability-Adjusted Life Years (DALY) related to RA in India from 1990 to 2021, while also observing variations across 31 geographical regions.Results: From 1990 to 2021 in India, the incidence, prevalence, and DALY rates of RA showed an increasing trend, with all age-standardized rates being significantly higher in females than in males. The age group of 65-69 years showed the highest incidence rate, while the prevalence peaked at 75-79 years. The forecast results indicate that the age-standardized incidence and prevalence rates of RA in India will show an upward trend from 2022 to 2036. There were considerable differences in prevalence across different regions. In 2021, the highest male prevalence was in Uttarakhand, while Goa had the lowest. For females, Tamil Nadu had the highest prevalence, and Madhya Pradesh had the lowest. Overall, areas with high Socio-Demographic Index (SDI) showed a higher disease burden, whereas Kerala, despite a higher SDI, had the lowest burden.Conclusion: Using the GBD database, our findings show that the disease burden of RA in India is on the rise from 1990 to 2021. The prevalence of RA in different regions of India is significantly different, which may be related to local economy and development. The high prevalence of RA in Indian women requires more attention to the early diagnosis and treatment of RA.
Keywords: Epidemiology, Prevalence, Incidence, disease burden, Rheumatoid arthritis
Received: 26 Nov 2024; Accepted: 30 Jan 2025.
Copyright: © 2025 Shi, Liang, Zhang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Huafeng Zhang, Tianjin Medical University General Hospital, Tianjin, China
Hui Li, Tianjin Medical University General Hospital, Tianjin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.